|Manufacturer:||Merck Sharpe & Dohme manufactures Cosopt.|
|Uses:||The uses of Cosopt include:|
COSOPT is indicated for the treatment of elevated intraocular pressure (IOP) in patients with:
or other secondary open-angle glaucoma's
and who are:
insufficiently responsive to topical beta blocker monotherapy
currently receiving concomitant antiglaucoma therapies such as dorzolamide HCI and timolol maleate.
Dosage and Administration:
The dose is one drop of COSOPT in the affected eye(s) two times daily. When substituting COSOPT for another ophthalmic antiglaucoma agent(s), discontinue the other agent(s) after proper dosing on one day, and start COSOPT on the next day.
If another topical ophthalmic agent is being used, COSOPT and the other agent should be administered at least ten minutes apart.
Safety and efficacy in paediatric patients below the age of 2 years have not been established. (For information regarding use in paediatric patients ¡Ý2 years of age see Warnings and Precautions, Paediatric Use).